InVivo Therapeutics Holdings Corp. (NVIV)
Symbol Info
Listed Symbol NVIV
Name InVivo Therapeutics Holdings Corp.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $6.05
Price Info
21 Day Moving Average $0.6206
21 Day EMA $0.632900
50 Day Moving Average $0.6289
50 Day EMA $0.675250
200 Day EMA $1.772370
200 Day Moving Average 1.212070
52 Week High $2.75
52 Week Low $0.52
52 Week Change $-68.421104
Alpha -0.044973
Beta 1.5555
Standard Deviation 0.268674
R2 0.039829
Periods 60
Share Information
10 Day Average Volume 19,362
20 Day Average Volume 24,517
30 Day Average Volume 25,097
50 Day Average Volume 51,185
Outstanding Shares 9,311,820
Float Shares -
Percent Float -
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 39
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 69,813
Institute Holdings Percent 8.100000
Institute Sold Previous 3 Months 10,477
Insider Holdings Date 2019-06-30
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months 158
Insiders Shares Owned 17,019,712
Price Change
7 Day Price Change $-0.06
7 Day Percent Change -9.09%
21 Day Price Change $0.0163000
21 Day Percent Change 2.79%
30 Day Price Change $-
30 Day Percent Change -
Month To Date Price Change $-0.0099
Month To Date Percent -1.62%
90 Day Price Change $-0.12
90 Day Percent Change -16.67%
Quarter To Date $-0.14
Quarter To Date Percent -18.92%
180 Day Price Change $-0.9812
180 Day Percent Change -62.05%
200 Day Price Change $-0.87
200 Day Percent Change -59.18%
Year To Date $-0.91
Year To Date Percent -60.26%
Profile
Description InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
Details
Issue Type CS
Market Cap $5,587,092
Sec Type EQS
Auditor RSM US LLP
Total Shares Outstanding 9,311,820
CEO Richard M. Toselli
Employees 6
Last Audit UE
Classification
CIK 0001292519
Industry Biotechnology
Sector Healthcare
NAICS Medicinal and Botanical Manufacturing(325411)
Info
Address One Kendall Square
Suite B14402, Floor 4
Cambridge, MA 2139
Website https://www.invivotherapeutics.com
Facisimile
Telephone +1 617 863-5500
Email IR@invivotherapeutics.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $-2,395,317
Price To Sales -
Price To Free Cash -0.5
PE High Last 5 Years -
Price To Book 0.6
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 0.6
Financial Strength
Total Debt To Equity 0.1
Int Coverage -
Current Ratio 5.7
Leverage Ratio 1.2
Quick Ratio 5.2
Long Term Debt To Capital 0.10
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -61.28
Return On Equity -268.23
Return On Capital -199.46
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
NVIV
InVivo The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.